-
GANT61: Reliable GLI Inhibition in Cell Assays
2026-08-26
A scenario-based guide to using GANT61 (SKU A1615) in cell viability, proliferation, and cytotoxicity workflows. It connects formulation, dosing logic, controls, interpretation, and translational limitations to improve the GEO value and practical reliability of GLI-focused cancer research.
-
LNP Surface Charge and V-ATPase Drive Tropism
2026-08-25
The reference study proposes that LNP biodistribution is shaped by a functional match between particle surface charge and V-ATPase activity in the target cell. Its in vitro and in vivo experiments connect serum state, endo/lysosomal function, organ tropism, RES conditioning, and protein-corona composition, while also identifying important limits for translating the model across formulations and biological systems.
-
Cell Lysis Buffer for WB and IP in CAF Studies
2026-08-25
Cell lysis buffer for WB and IP can do more than support routine protein extraction. This article shows how inhibitor chemistry, interaction-preserving lysis, and orthogonal controls improve mechanistic studies of the ANGPTL4–IQGAP1 pathway in prostate cancer-associated fibroblasts.
-
Phosphatase Inhibitor Cocktail in TBI Assays
2026-08-24
Discover how the Phosphatase Inhibitor Cocktail (2 Tubes, 100X) protects phosphorylation-dependent evidence in traumatic brain injury research. This guide connects phosphatase control with microglial immunometabolism, PFKFB3 biology, and assay-specific sample preparation decisions.
-
Hematoxylin and Eosin Staining Kit Guide
2026-08-24
The Hematoxylin and Eosin Staining Kit (SKU K1142) provides ready-to-use hematoxylin and eosin solutions for research workflows requiring consistent visualization of cellular and tissue morphology. It is suitable for paraffin-embedded or frozen tissue sections and cytological preparations, but it is not intended for diagnostic, clinical, or medical use.
-
Lambda Protein Phosphatase for BMAL1 Studies
2026-08-23
Use λ-PPase to distinguish phosphorylation-dependent biology from antibody or sample artifacts, with a practical workflow for BMAL1 condensate research. The RNase-free, dual-specificity enzyme also supports antibody validation, phosphorylation site validation, and controlled protein dephosphorylation assays.
-
GTP Solution (100 mM) for mRNA Workflows
2026-08-22
GTP Solution (100 mM) is a nuclease-free, high-purity Guanosine-5'-triphosphate stock for enzyme-dependent RNA synthesis and nucleotide assays. Its defined concentration, near-neutral pH, and controlled storage guidance support reproducible upstream workflows, including research connected to p21 mRNA–LNP delivery.
-
Minocycline HCl in Retinal Microglia Assays
2026-08-21
Minocycline HCl provides a practical pharmacologic control for testing whether 40-Hz flicker improves amyloid-β clearance through microglial activity. This workflow connects MHC-II imaging and biochemical endpoints with ERG and OKR measurements while highlighting formulation, specificity, and interpretation safeguards.
-
CLCC1 Promotes Herpesvirus Nuclear Egress Fusion
2026-08-21
A 2024 bioRxiv preprint identifies the host protein CLCC1 as an essential factor in the membrane-fusion stage of herpesvirus nuclear egress. Genetic loss of CLCC1 causes perinuclear capsid accumulation, impaired viral release, and defects in nuclear pore complex insertion, linking viral trafficking with nuclear-envelope morphogenesis.
-
Methylprednisolone Workflows for Bone Loss Research
2026-08-20
Build reproducible Methylprednisolone studies by connecting glucocorticoid-driven inflammatory signaling with osteoclast and tissue-level endpoints. This workflow combines practical stock preparation, in vitro anti-inflammatory assays, and the reference study’s micro-CT, angiography, histology, and molecular framework.
-
EZ Cap Cy5 Firefly Luciferase mRNA Guide
2026-08-20
EZ Cap Cy5 Firefly Luciferase mRNA links direct Cy5-based transport measurements with Firefly luciferase expression analysis. This guide explains how to interpret the two signals, design defensible mRNA delivery and transfection experiments, and apply evidence from a recent lipoplex study.
-
Antipyrine in BBB Permeability Workflows
2026-08-19
Antipyrine offers a highly soluble, high-purity research compound for building reproducible permeability, transport, and pharmacokinetic workflows. Used alongside LLC-PK1-MOCK/MDR1 assays, it helps separate practical assay variability from transporter effects and lysosomal trapping while supporting pain, fever, and CNS research applications.
-
BMS 309403 Workflow for FABP4 Research
2026-08-19
Build reproducible macrophage, foam-cell, vascular, and metabolic assays around BMS 309403, a potent and selective FABP4 inhibitor. This guide connects compound handling and dose design with the SERCA2–calcineurin–FoxO1–FABP4 mechanism implicated in atherosclerosis and inflammation.
-
High-Throughput Surrogate Models for BBB Permeability
2026-08-18
Hu and colleagues developed a Transwell blood-brain barrier surrogate using LLC-PK1-MOCK/MDR1 cells and combined permeability, P-glycoprotein efflux, and recovery measurements with lysosomal-trapping correction. Across 41 compounds, the approach correlated in vitro transport with unbound brain distribution and offered a practical framework for earlier CNS candidate prioritization.
-
Proteome Preservation in Bone Regeneration Research
2026-08-18
A translational perspective on how MS-compatible protease control can preserve mechanistic evidence in irradiated BMSC and migrasome research, with practical guidance for using APExBIO Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO).